On October 1, 2025, Onconetix, Inc. secured approximately $6.25 million through a PIPE financing deal, selling 7,813 shares of Series E convertible preferred stock and warrants for 2,025,223 shares of common stock. This transaction is significant as it indicates investor confidence and provides capital for the company's operations.